The Muscle Crisis in the GLP-1 Era: Dr. Rocío Salas-Whalen on the Critical Need for the "GPS" Framework
Executive Overview The rise of glucagon-like peptide-1 (GLP-1) receptor agonists—such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound)—has…
